ARC Stock Overview
ARCpoint Inc. provides drugs and alcohol testing services in Carolina.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
ARCpoint Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.08 |
52 Week High | CA$0.29 |
52 Week Low | CA$0.075 |
Beta | 0 |
1 Month Change | -5.88% |
3 Month Change | -42.86% |
1 Year Change | -42.86% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -84.00% |
Recent News & Updates
Recent updates
Shareholder Returns
ARC | CA Healthcare | CA Market | |
---|---|---|---|
7D | 6.7% | -1.2% | -1.1% |
1Y | -42.9% | -0.05% | 4.9% |
Return vs Industry: ARC underperformed the Canadian Healthcare industry which returned -0.1% over the past year.
Return vs Market: ARC underperformed the Canadian Market which returned 4.9% over the past year.
Price Volatility
ARC volatility | |
---|---|
ARC Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 5.0% |
Market Average Movement | 8.9% |
10% most volatile stocks in CA Market | 18.3% |
10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: ARC's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine ARC's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1998 | n/a | John Constantine | www.arcpointlabs.com |
ARCpoint Inc. provides drugs and alcohol testing services in Carolina. The company operates in two segments, ARCpoint Franchise and AFG Services. It offers clinical healthcare, corporate wellness programs, employment/background checks, DNA and Paternal DNA testing, covid and steroid testing, and legal, physician, and business and employer solutions, as well as DOT solutions and other performance-enhancing drugs testing services.
ARCpoint Inc. Fundamentals Summary
ARC fundamental statistics | |
---|---|
Market cap | CA$8.17m |
Earnings (TTM) | -CA$11.92m |
Revenue (TTM) | CA$9.18m |
0.9x
P/S Ratio-0.7x
P/E RatioIs ARC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ARC income statement (TTM) | |
---|---|
Revenue | US$6.67m |
Cost of Revenue | US$4.88m |
Gross Profit | US$1.79m |
Other Expenses | US$10.45m |
Earnings | -US$8.66m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.085 |
Gross Margin | 26.79% |
Net Profit Margin | -129.90% |
Debt/Equity Ratio | -67.4% |
How did ARC perform over the long term?
See historical performance and comparison